RPS20P5

Across TCGA pan-cancer cohorts, RPS20P5 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPS20P5 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPS20P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS20P5 expression acts as an unfavorable survival marker, although some lineages such as SKCM and THCA show a favorable association.

UVM, SKCM, and STAD are the cancer types where RPS20P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	All	0.521	0.860	<.001	109	view →
SKCM	OS	Tertile	II,III,IV	0.857	0.699	.001	75	view →
STAD	DFS	Median	II,III,IV	0.455	0.601	.001	43	view →
HNSC	DFS	Tertile	IV	0.532	0.671	.005	33	view →
THCA	DFS	Quartile	All	0.957	0.871	.005	23	view →
LAML	DFS	Median	All	0.399	0.729	<.001	18	view →
LUSC	OS	Tertile	IV	0.001	0.651	.025	18	view →
KIRP	OS	Tertile	All	1.000	0.835	.025	16	view →
KICH	DFS	Quartile	III,IV	0.309	0.840	.020	12	view →
CHOL	DFS	Tertile	All	0.133	0.496	.033	9	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	9	view →
PAAD	DFS	Tertile	All	0.208	0.417	.022	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPS20P5–UVM (DFS)

Open the UVM breakdown →